Epsilon Molecular Engineering List of News Articles

Epsilon Molecular Engineering Co., Ltd. (Headquarters: Saitama City, Saitama Prefecture, President: Naoto Nemoto, hereinafter referred to as EME) has entered into a joint research and development agreement with JCR Pharmaceuticals Co., Ltd. (Headquarters: Ashiya City, Hyogo Prefecture, Chairman and President: Shin Ashida, hereinafter referred to as JCR Pharmaceuticals) to utilize EME's unique humanized VHH screening platform (a combination of the "PharmaLogical Library" (*1) and cDNA display technology (*2) for efficiently acquiring VHH antibodies suitable for drug discovery, hereinafter referred to as the platform) for drug discovery related to next-generation VHH antibodies (*3).

Mitsui Information Co., Ltd. (Headquarters: Minato-ku, Tokyo, President: Kengo Asano, hereinafter referred to as Mitsui Information) and Epsilon Molecular Engineering Co., Ltd. (Headquarters: Saitama City, Saitama Prefecture, President: Naoto Nemoto, hereinafter referred to as EME) announced the completion of the joint development of the PharmaLogical Library, Japan's first next-generation humanized library of VHH antibodies for drug discovery, and its transition to the implementation phase. Mitsui Information and EME will continue to utilize the PharmaLogical Library to acquire, design, and optimize VHH antibodies that lead to drug discovery, thereby supporting pharmaceutical companies in improving the speed of research and the reliability of drug development.